MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Intermediaries
Private Equity, Investment Banking, Financial Services, Factoring
Analysts, Investment Banks: Top Performing Recommendations & Analysis
Finance & Acquisitions: BAKER BROTHERS ADVISORS LP
Newlink Genetics (NASDAQ:NLNK)
Organization & Developments: Newlink
Parents
Newlink Genetics (NASDAQ:NLNK)
Children
2014: NewLink in $1 billion deal with Roche to develop cancer drug
2017: NewLink Genetics Data Catches Wall Street By Surprise - NewLink Genetics Corporation (NASDAQ:NLNK)
2018: NewLink Genetics shares plummet 39% after Merck, Incyte trial failure
2019: Failed NewLink goes dark in a reverse merger, as Lumos jumps on board for a ride to Wall Street – Endpoints News
Industry: Biotechnology Sub-Industry: N/A
NewLink Genetics is a biopharmaceutical company applying innovative approaches to create new therapeutic and diagnostic agents for patients with cancer and infectious diseases.
Jumps
*Key People: Newlik
Finance & Acquisitions: Newlink